Home › Bronchiolitis Obliterans Syndrome › Pennsylvania
Bronchiolitis Obliterans Syndrome clinical trials in Pennsylvania
11 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
- Childrens Hospital of Pittsburgh, Pittsburgh
RecruitingPhase 2
Ages 2 to 17 · All sexes · Updated Sep 15, 2026 · NCT07124078A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Jefferson University Hospitals, Philadelphia
- Upmc Hillman Cancer Center, Pittsburgh
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT06585774Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
- University of Pittsburgh, Pittsburgh
RecruitingHealthy volunteers welcome
Ages 12 and older · All sexes · Updated Sep 3, 2026 · NCT02592291Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Geisinger Health Systems, Danville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05919511Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
- Fox Chase Cancer Center, Philadelphia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06660355A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
- Hospital of the University of Pennsylvania, Philadelphia
RecruitingPhase 1/2Healthy volunteers welcome
Ages 12 to 85 · All sexes · Updated Jun 11, 2026 · NCT04959175A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of Pennsylvania, Philadelphia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06615050Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
- Temple Digestive Disease Center, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT06464926Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury
- Thomas Jefferson University Center City Campus, Philadelphia
Recruiting
Ages 18 to 70 · All sexes · Updated Feb 5, 2026 · NCT07135583A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.